Rchr
J-GLOBAL ID:202101002171965981   Update date: Oct. 13, 2023

Murayama Yuichi

ムラヤマ ユウイチ | Murayama Yuichi
Affiliation and department:
Job title: Professor
Papers (345):
  • M Fuga, T Tanaka, R Tachi, S Yamana, K Irie, I Kajiwara, A Teshigawara, T Ishibashi, Y Hasegawa, Y Murayama. Contrast Injection from an Intermediate Catheter Placed in an Intradural Artery is Associated with Contrast-Induced Encephalopathy following Neurointervention. AJNR. American journal of neuroradiology. 2023
  • Michiyasu Fuga, Toshihide Tanaka, Rintaro Tachi, Kyoichi Tomoto, Kenta Kazami, Akihiko Teshigawara, Toshihiro Ishibashi, Yuzuru Hasegawa, Yuichi Murayama. Risk factors for radial artery occlusion after neurointervention for unruptured intracranial aneurysm via transradial access. Interventional neuroradiology : journal of peritherapeutic neuroradiology, surgical procedures and related neurosciences. 2023. 15910199231189927-15910199231189927
  • Michiyasu Fuga, Toshihide Tanaka, Rintaro Tachi, Koreaki Irie, Ikki Kajiwara, Akihiko Teshigawara, Toshihiro Ishibashi, Yuzuru Hasegawa, Yuichi Murayama. Efficacy and safety of fetal posterior cerebral artery stented coil embolization for fetal posterior cerebral aneurysms. Interventional neuroradiology : journal of peritherapeutic neuroradiology, surgical procedures and related neurosciences. 2023. 15910199231188556-15910199231188556
  • Jun Takei, Yuko Kamata, Toshihide Tanaka, Nei Fukasawa, Kazutaka Gomisawa, Mari Satake, Ryosuke Mori, Yohei Yamamoto, Tomoya Suzuki, Ayaka Oda, et al. Prognostic survival biomarkers of tumor-fused dendritic cell vaccine therapy in patients with newly diagnosed glioblastoma. Cancer immunology, immunotherapy : CII. 2023
  • Tomoya Suzuki, Jun Takei, Nei Fukasawa, Kenta Suzuki, Daisuke Ogawa, Yohei Yamamoto, Yasuharu Akasaki, Yuichi Murayama, Masayuki Shimoda, Keisuke Miyake, et al. FMISO-PET and immunohistochemistry verified tumor oxygenation, stemness, and immunosupportive microenvironment after preoperative neoadjuvant bevacizumab for newly diagnosed glioblastoma. World neurosurgery. 2023
more...
MISC (82):
  • Akasaki Y, Kikuchi T, Tanaka T, Murayama Y. Dendritic cell immunotherapy for malignant glioma: Research history for 25 years and the future perspectives. Neuro-Oncology Advances. 2022. 4. 3. iii27
  • Akasaki Y, Suzuki T, Takei J, Tanaka T, Mori R, Koseki H, Yamamoto Y, Teshigawara A, Kamata Y, Yanagisawa T, et al. Pros and cons of surgical intervention for diffuse midline glioma aimed at dendritic cell immunotherapy. Neuro-Oncology Advances. 2022. 4. 3. iii12
  • Yamamoto Y, Nawate S, Nakamura A, Ishii T, Tanaka T, Akasaki Y, Murayama Y. Analysis of metastatic brain tumors discovered at the same time as the primary lesion. Neuro-Oncology Advances. 2022. 4. 3. iii21-iii22
  • Tohmoto K, Yamamoto Y, Tanaka T, Suzuki T, Teshigawara A, Takei J, Koseki H, Mori R, Akasaki Y, Murayama Y. Clinical benefit of add-on bevacizumab for newly diagnosed glioblastoma in elderly patients with unresectable and poor performance status. Neuro-Oncology Advances. 2022. 4. 3. iii8
  • Tanaka T, Tamura R, Takei J, Morimoto Y, Teshigawara A, Tohmoto K, K, Kuranari Y, Imai R, Yamamoto Y, et al. A prospective multicenter phase I/IIa study of prospective neoadjuvant bevacizumab for newly diagnosed glioblastoma. Neuro-Oncology Advances. 2022. 4. 3. iii7
more...
Lectures and oral presentations  (1):
  • ハイブリッド手術室を駆使した高難易度脳動脈瘤治療戦略
    (第30回脳神経外科手術と機器学会 2021)
Education (1):
  • 1983 - 1989 Jikei University
Work history (1):
  • 2013/04 - 現在 Jikei University Department of Neurosurgery Professor
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page